Rocky Mountain Cancer Centers is a clinical research site located in Colorado Springs, Colorado, United States 80907.
Crixeo Clinical Trials Trust Score: 83/100 (GOOD). This profile has not yet been claimed by the site owner.
Rocky Mountain Cancer Centers has participated in 26 clinical trials with 7 currently active.
Therapeutic areas: Metastatic Renal Cell Carcinoma, Advanced Solid Tumor, Advanced, Androgen Receptor Positive Triple Negative Breast Cancer.
Sponsors: Pfizer, Janssen Research & Development, LLC, Novacea.
Trust Score: 83/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Rocky Mountain Cancer Centers has a Crixeo Trust Score of 83/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Rocky Mountain Cancer Centers has 26 clinical trials on record, with 7 currently active. Their work covers Metastatic Renal Cell Carcinoma, Advanced Solid Tumor, Advanced, Androgen Receptor Positive Triple Negative Breast Cancer.
Rocky Mountain Cancer Centers has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.